These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 15583006

  • 21. Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation.
    Lopez I, Duprez V, Melle J, Dreyfus F, Lévy-Tolédano S, Fontenay-Roupie M.
    Biochem J; 2001 Jun 15; 356(Pt 3):875-81. PubMed ID: 11389697
    [Abstract] [Full Text] [Related]

  • 22. GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk.
    Hughan SC, Hughes CE, McCarty OJ, Schweighoffer E, Soultanova I, Ware J, Tybulewicz VL, Watson SP.
    Arterioscler Thromb Vasc Biol; 2007 Feb 15; 27(2):422-9. PubMed ID: 17110603
    [Abstract] [Full Text] [Related]

  • 23. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T, Yatomi Y, Asazuma N, Satoh K, Ozaki Y.
    Biochem J; 2000 Apr 15; 347(Pt 2):561-9. PubMed ID: 10749687
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
    Cheung HYF, Moran LA, Sickmann A, Heemskerk JWM, Garcia Á, Watson SP.
    Platelets; 2022 Nov 17; 33(8):1293-1300. PubMed ID: 35535424
    [Abstract] [Full Text] [Related]

  • 25. A critical role for the regulation of Syk from agglutination to aggregation in human platelets.
    Shih CH, Chiang TB, Wang WJ.
    Biochem Biophys Res Commun; 2014 Jan 10; 443(2):580-5. PubMed ID: 24326074
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.
    Bhavaraju K, Kim S, Daniel JL, Kunapuli SP.
    Eur J Pharmacol; 2008 Feb 12; 580(3):285-90. PubMed ID: 18068154
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein.
    Brunati AM, Deana R, Folda A, Massimino ML, Marin O, Ledro S, Pinna LA, Donella-Deana A.
    J Biol Chem; 2005 Jun 03; 280(22):21029-35. PubMed ID: 15795233
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Rapid ubiquitination of Syk following GPVI activation in platelets.
    Dangelmaier CA, Quinter PG, Jin J, Tsygankov AY, Kunapuli SP, Daniel JL.
    Blood; 2005 May 15; 105(10):3918-24. PubMed ID: 15701717
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3.
    Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ.
    EMBO J; 1997 Nov 03; 16(21):6414-25. PubMed ID: 9351824
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A Ras activation pathway dependent on Syk phosphorylation of protein kinase C.
    Kawakami Y, Kitaura J, Yao L, McHenry RW, Kawakami Y, Newton AC, Kang S, Kato RM, Leitges M, Rawlings DJ, Kawakami T.
    Proc Natl Acad Sci U S A; 2003 Aug 05; 100(16):9470-5. PubMed ID: 12881490
    [Abstract] [Full Text] [Related]

  • 40. The use of selective pharmacological inhibitors to delineate signal transduction pathways activated during complement receptor-mediated degranulation in chicken heterophils.
    Kogut MH, Lowry VK, Farnell M.
    Int Immunopharmacol; 2003 May 05; 3(5):693-706. PubMed ID: 12757738
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.